- Recently uplisted to Nasdaq, trading under symbol “KAVL”
- KAVL plans to launch proprietary line of CBD products under its Kaival Labs subsidiary, marking the first Kaival-branded product
- Company sent LOI to potential launch partner for in-house and white-label production
Following its recent uplist to the Nasdaq exchange, Kaival Brands Innovations Group (NASDAQ: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands, recently announced plans to launch a new line of cannabidiol (“CBD”) products (https://ibn.fm/7Lcd4).
The company intends to follow a similar design path set by its highly successful Bidi(R) Stick product, using the same first-in-class, patented delivery mechanism that gives its loyal consumer base a unique and premium vaping experience. Along with providing users with a convenient...
NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.